A meta-analysis evaluating eight studies and 1102 patients with cancers of the lung, stomach, liver, and biliary tract; lymphoma; and myeloma indicated that a higher level of sPD-L1 was associated with worse OS (HR = 1.60, 95% CI: 1.21–1.99) [30]. This evidence concerns the gene SPDL1 and cancer.